{"id":505719,"date":"2021-06-23T06:58:25","date_gmt":"2021-06-23T10:58:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/"},"modified":"2021-06-23T06:58:25","modified_gmt":"2021-06-23T10:58:25","slug":"bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/","title":{"rendered":"BD Announces Expanded 510(k) Clearance for At-Home System for Ascites"},"content":{"rendered":"
\n

PeritX\u2122 Peritoneal Catheter System is the first and only at-home system indicated for malignant and non-malignant ascites drainage in the United States.<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n FRANKLIN LAKES, N.J.<\/span>, June 23, 2021<\/span> \/PRNewswire\/ —\u00a0BD (Becton, Dickinson and Company) (NYSE:\u00a0BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the PeritX\u2122 Peritoneal Catheter System for the drainage of symptomatic, recurrent non-malignant ascites. Ascites is a debilitating condition that causes the build-up of fluid in the abdomen.<\/p>\n

\n

\n
\n \"PeritX
\n <\/a>\n <\/p>\n<\/p><\/div>\n

The PleurX\u2122 Peritoneal Catheter System was introduced in 2005 for the drainage of malignant ascites. With the new, expanded indication, the system is being rebranded as the PeritX\u2122 Peritoneal Catheter System to make it easier for physicians to navigate BD’s portfolio of at-home drainage products. The PeritX\u2122 Peritoneal Catheter System is the first and only FDA indicated tunneled catheter for the drainage of malignant and non-malignant ascites and for the palliation of symptoms related to recurrent ascites.<\/p>\n

“The new, expanded indication for the\u00a0PeritX\u2122 Peritoneal Catheter System will allow us to help more patients who present with ascites due to liver disease or other noncancer-related origins,” said Padraic O’Brien<\/span>, Worldwide President of Peripheral Intervention for BD.\u00a0“Recurrent ascites is a debilitating condition that requires the patient to make frequent trips to the hospital so that fluid can be removed from the peritoneum. The PeritX\u2122 Peritoneal Catheter System allows patients to manage non-malignant ascites at home and aligns with our goal to help keep patients out of the hospital.”<\/p>\n

Ascites is a condition in which fluid collects in spaces within the abdomen. It can make ordinary daily activities more challenging. The fluid may also move to the chest and surround the lungs, making breathing more difficult. <\/p>\n

“Patients with ascites are often managing multiple serious medical conditions. The PeritX\u2122 Peritoneal Catheter System provides relief from the discomfort of ascites fluid build-up, at home, enabling patients to spend more time with their loved ones,” O’Brien concluded.<\/p>\n

\n About BD
<\/b>BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com<\/a> or connect with us on LinkedIn at www.linkedin.com\/company\/bd1\/<\/a> and Twitter @BDandCo<\/a>. <\/p>\n

\n\n\n\n\n\n\n\n\n
\n

\n
\n Contacts:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Media<\/b>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Investors<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Paul Tyahla\u00a0<\/span>\n <\/p>\n<\/td>\n

\n

\n Kristen M. Stewart, CFA<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n BD Public Relations <\/span>\n <\/p>\n<\/td>\n

\n

\n BD SVP, Strategy & Investor Relations<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n 908.873.4412 <\/span>\n <\/p>\n<\/td>\n

\n

\n 201.847.5378\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n paul.tyahla@bd.com<\/a>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n kristen.stewart@bd.com<\/a>\u00a0\u00a0 <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n

\n
\n \"BD
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites-301317926.html<\/a><\/p>\n

SOURCE BD (Becton, Dickinson and Company)<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PeritX\u2122 Peritoneal Catheter System is the first and only at-home system indicated for malignant and non-malignant ascites drainage in the United States. PR Newswire FRANKLIN LAKES, N.J., June 23, 2021 \/PRNewswire\/ —\u00a0BD (Becton, Dickinson and Company) (NYSE:\u00a0BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the PeritX\u2122 Peritoneal Catheter System for the drainage of symptomatic, recurrent non-malignant ascites. Ascites is a debilitating condition that causes the build-up of fluid in the abdomen. The PleurX\u2122 Peritoneal Catheter System was introduced in 2005 for the drainage of malignant ascites. With the new, expanded indication, the system is being rebranded as the PeritX\u2122 Peritoneal Catheter System to make it … <\/p>\n

Continue reading “BD Announces Expanded 510(k) Clearance for At-Home System for Ascites”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-505719","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBD Announces Expanded 510(k) Clearance for At-Home System for Ascites - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BD Announces Expanded 510(k) Clearance for At-Home System for Ascites - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PeritX\u2122 Peritoneal Catheter System is the first and only at-home system indicated for malignant and non-malignant ascites drainage in the United States. PR Newswire FRANKLIN LAKES, N.J., June 23, 2021 \/PRNewswire\/ —\u00a0BD (Becton, Dickinson and Company) (NYSE:\u00a0BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the PeritX\u2122 Peritoneal Catheter System for the drainage of symptomatic, recurrent non-malignant ascites. Ascites is a debilitating condition that causes the build-up of fluid in the abdomen. The PleurX\u2122 Peritoneal Catheter System was introduced in 2005 for the drainage of malignant ascites. With the new, expanded indication, the system is being rebranded as the PeritX\u2122 Peritoneal Catheter System to make it … Continue reading "BD Announces Expanded 510(k) Clearance for At-Home System for Ascites"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-23T10:58:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1539093\/PeritX_peritoneal_cavity_BD.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BD Announces Expanded 510(k) Clearance for At-Home System for Ascites\",\"datePublished\":\"2021-06-23T10:58:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\\\/\"},\"wordCount\":565,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1539093\\\/PeritX_peritoneal_cavity_BD.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\\\/\",\"name\":\"BD Announces Expanded 510(k) Clearance for At-Home System for Ascites - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1539093\\\/PeritX_peritoneal_cavity_BD.jpg\",\"datePublished\":\"2021-06-23T10:58:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1539093\\\/PeritX_peritoneal_cavity_BD.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1539093\\\/PeritX_peritoneal_cavity_BD.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BD Announces Expanded 510(k) Clearance for At-Home System for Ascites\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BD Announces Expanded 510(k) Clearance for At-Home System for Ascites - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/","og_locale":"en_US","og_type":"article","og_title":"BD Announces Expanded 510(k) Clearance for At-Home System for Ascites - Market Newsdesk","og_description":"PeritX\u2122 Peritoneal Catheter System is the first and only at-home system indicated for malignant and non-malignant ascites drainage in the United States. PR Newswire FRANKLIN LAKES, N.J., June 23, 2021 \/PRNewswire\/ —\u00a0BD (Becton, Dickinson and Company) (NYSE:\u00a0BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the PeritX\u2122 Peritoneal Catheter System for the drainage of symptomatic, recurrent non-malignant ascites. Ascites is a debilitating condition that causes the build-up of fluid in the abdomen. The PleurX\u2122 Peritoneal Catheter System was introduced in 2005 for the drainage of malignant ascites. With the new, expanded indication, the system is being rebranded as the PeritX\u2122 Peritoneal Catheter System to make it … Continue reading \"BD Announces Expanded 510(k) Clearance for At-Home System for Ascites\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-23T10:58:25+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1539093\/PeritX_peritoneal_cavity_BD.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BD Announces Expanded 510(k) Clearance for At-Home System for Ascites","datePublished":"2021-06-23T10:58:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/"},"wordCount":565,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1539093\/PeritX_peritoneal_cavity_BD.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/","name":"BD Announces Expanded 510(k) Clearance for At-Home System for Ascites - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1539093\/PeritX_peritoneal_cavity_BD.jpg","datePublished":"2021-06-23T10:58:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1539093\/PeritX_peritoneal_cavity_BD.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1539093\/PeritX_peritoneal_cavity_BD.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-announces-expanded-510k-clearance-for-at-home-system-for-ascites\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BD Announces Expanded 510(k) Clearance for At-Home System for Ascites"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/505719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=505719"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/505719\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=505719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=505719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=505719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}